Compile Data Set for Download or QSAR
Found 33 with Last Name = 'kudoh' and Initial = 'm'
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18656((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataKi:  4.60nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Rattus norvegicus (Rat))
Astellas Pharma Inc.

LigandPNGBDBM18656((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataKi:  6.20nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Rattus norvegicus (Rat))
Astellas Pharma Inc.

LigandPNGBDBM18525(Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...)copy SMILEScopy InChI
Affinity DataKi:  14nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18525(Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...)copy SMILEScopy InChI
Affinity DataKi:  19nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
TargetProgesterone receptor(Rattus norvegicus)
Astellas Pharma Inc.

LigandPNGBDBM18656((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataKi:  3.30E+3nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetProgesterone receptor(Rattus norvegicus)
Astellas Pharma Inc.

LigandPNGBDBM18525(Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...)copy SMILEScopy InChI
Affinity DataKi:  7.20E+3nMAssay Description:The Ki values were determined by the application of the Cheng-Prusoff equation: Ki=IC50/(1+[L]/Kd] where [L] is the concentration of labeled ligand a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18656((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 110nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18636((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 120nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18645((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 130nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18637((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 140nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18649((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(6...)copy SMILEScopy InChI
Affinity DataIC50: 170nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18646((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(2...)copy SMILEScopy InChI
Affinity DataIC50: 190nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18654((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(6...)copy SMILEScopy InChI
Affinity DataIC50: 200nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18634((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(2...)copy SMILEScopy InChI
Affinity DataIC50: 200nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18655(4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl...)copy SMILEScopy InChI
Affinity DataIC50: 210nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18650((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 220nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18644((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 250nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18643((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 330nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18659((2R,5S)-N-(6-aminopyridin-3-yl)-4-[4-cyano-3-(trif...)copy SMILEScopy InChI
Affinity DataIC50: 370nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18648((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(5...)copy SMILEScopy InChI
Affinity DataIC50: 440nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18652(N-Arylpiperazine-1-carboxamide Derivative, 30 | me...)copy SMILEScopy InChI
Affinity DataIC50: 470nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18653((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(6...)copy SMILEScopy InChI
Affinity DataIC50: 500nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18642((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 680nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18651((2R,5S)-N-(6-chloropyridin-3-yl)-4-[4-cyano-3-(tri...)copy SMILEScopy InChI
Affinity DataIC50: 730nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18525(Bicalutamide | CHEMBL409 | N-[4-cyano-3-(trifluoro...)copy SMILEScopy InChI
Affinity DataIC50: 890nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18640((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18647((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(4...)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+3nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18657((2S,5R)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18639((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 4.60E+3nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18635((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 7.80E+3nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18641(3-{[(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18638((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed
TargetAndrogen receptor(Homo sapiens (Human))
Astellas Pharma Inc.

LigandPNGBDBM18658((2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-N-(6...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMpH: 7.8Assay Description:Activities of the test compounds to inhibit androgen receptor mediated transcription induced by DHT were evaluated using stable transfected AR/CHO#3 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2P84952PubMed